Differential importance of endothelial and hematopoietic cell GLP-1Rs for cardiometabolic versus hepatic actions of semaglutide

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are used to treat diabetes and obesity and reduce rates of major cardiovascular events, such as stroke and myocardial infarction. Nevertheless, the identity of GLP-1R–expressing cell types mediating the cardiovascular benefits of GLP-1RA remains i...

Descripción completa

Detalles Bibliográficos
Autores principales: McLean, Brent A., Wong, Chi Kin, Kaur, Kiran Deep, Seeley, Randy J., Drucker, Daniel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663785/
https://www.ncbi.nlm.nih.gov/pubmed/34673572
http://dx.doi.org/10.1172/jci.insight.153732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8663785/
https://www.ncbi.nlm.nih.gov/pubmed/34673572
http://dx.doi.org/10.1172/jci.insight.153732

Ejemplares similares